Newtyn Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28,000	Closed	-$889K	–	50
2023 Q3	$889K	Buy	+28,000	New	+$889K	0.22%	39